Executive Orders to Lower Prescription Drug Prices

President Donald Trump recently signed a series of Executive Orders aimed to address concerns of rising prescription drug prices on July 24, 2020. The four Executive Orders largely seek to empower the Department of Health and Human Services (HHS) to...

Read More

A Flood of Lawsuits as States Begin to Re-open

The COVID-19 pandemic brought with it a plethora of legal uncertainties and caused businesses throughout the country to confront previously unimagined litigation risks. Chief among these obstacles is a rise of litigation as a result of harms and breaches caused...

Read More

Department of Justice Sentencing Guidelines: Is your Corporate Compliance Program “Well-Designed”?

In early June, the Department of Justice (DOJ) published an updated guidance for the evaluation of corporate compliance programs. The sufficiency of a corporate compliance program is an important factor for prosecutors to consider when determining whether to bring charges...

Read More

Cybersecurity Considerations in the Wake of COVID-19

The COVID-19 global pandemic has affected all aspects of life. The coronavirus has caused many changes in our daily lives. For many companies, it is the first time that they have been forced to confront the numerous cybersecurity challenges associated...

Read More

Who will gain control of the “budding” marijuana business?

While some pharmaceutical companies may not think very highly of marijuana, others are jumping on the bandwagon and attempting to navigate this uncertain and ever-changing market in an attempt to grow their revenues. With states legalizing marijuana in various forms...

Read More